Artwork

Contenido proporcionado por TGen Talks. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente TGen Talks o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Player FM : aplicación de podcast
¡Desconecta con la aplicación Player FM !

Episode 70: United Against Brain Cancer

15:35
 
Compartir
 

Manage episode 415325386 series 1936276
Contenido proporcionado por TGen Talks. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente TGen Talks o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Glioblastoma. It’s the most aggressive and least treatable type of brain cancer. Research into treatment has been slow, mostly because of the difficulty in accessing and treating a tumor that exists behind the blood-brain barrier. A new two year fellowship into Glioblastoma Multiforme, or GBM, aims to better drug therapies to fight the cancer while developing better tests to determine which drugs are working on an individual patient's tumor and which are not. The fellowship, established by Shawn Lane and the Lori Lane Foundation together with Chris and Florence Spyrow, honors Lori Lane and Andrew Spyrow, whose lives were cut short by GBM. This month on TGen Talks, Valerie De Luca, Ph.D., the inaugural Lori Lane/Andrew Spyrow Fellow at TGen discusses her work toward improving our understanding of molecular markers associated with tumor vulnerability to specific drugs.
  continue reading

82 episodios

Artwork
iconCompartir
 
Manage episode 415325386 series 1936276
Contenido proporcionado por TGen Talks. Todo el contenido del podcast, incluidos episodios, gráficos y descripciones de podcast, lo carga y proporciona directamente TGen Talks o su socio de plataforma de podcast. Si cree que alguien está utilizando su trabajo protegido por derechos de autor sin su permiso, puede seguir el proceso descrito aquí https://es.player.fm/legal.
Glioblastoma. It’s the most aggressive and least treatable type of brain cancer. Research into treatment has been slow, mostly because of the difficulty in accessing and treating a tumor that exists behind the blood-brain barrier. A new two year fellowship into Glioblastoma Multiforme, or GBM, aims to better drug therapies to fight the cancer while developing better tests to determine which drugs are working on an individual patient's tumor and which are not. The fellowship, established by Shawn Lane and the Lori Lane Foundation together with Chris and Florence Spyrow, honors Lori Lane and Andrew Spyrow, whose lives were cut short by GBM. This month on TGen Talks, Valerie De Luca, Ph.D., the inaugural Lori Lane/Andrew Spyrow Fellow at TGen discusses her work toward improving our understanding of molecular markers associated with tumor vulnerability to specific drugs.
  continue reading

82 episodios

Todos os episódios

×
 
Loading …

Bienvenido a Player FM!

Player FM está escaneando la web en busca de podcasts de alta calidad para que los disfrutes en este momento. Es la mejor aplicación de podcast y funciona en Android, iPhone y la web. Regístrate para sincronizar suscripciones a través de dispositivos.

 

Guia de referencia rapida